ArticleESMO open2023

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.

D König et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.